Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Novartis
Chubb
Cantor Fitzgerald
McKinsey
Johnson and Johnson
Federal Trade Commission
Teva
Daiichi Sankyo

Generated: October 16, 2017

DrugPatentWatch Database Preview

Rockwell Medical Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ROCKWELL MEDICAL INC, and what generic alternatives to ROCKWELL MEDICAL INC drugs are available?

ROCKWELL MEDICAL INC has two approved drugs.

There are three US patents protecting ROCKWELL MEDICAL INC drugs.

There are thirty-two patent family members on ROCKWELL MEDICAL INC drugs in twenty-one countries.

Summary for Applicant: Rockwell Medical Inc

International Patents:32
US Patents:3
Tradenames:1
Ingredients:1
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-002Sep 4, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes► Subscribe► Subscribe ► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
FOR SOLUTION;INTRAVENOUS208551-001Apr 25, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes► Subscribe► Subscribe ► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Rockwell Medical Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015► Subscribe► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Rockwell Medical Inc Drugs

Country Document Number Estimated Expiration
Japan2009108027► Subscribe
Canada2638081► Subscribe
CroatiaP20120416► Subscribe
Austria554754► Subscribe
Austria311180► Subscribe
Hong Kong1023350► Subscribe
Australia736053► Subscribe
Spain2383713► Subscribe
Poland334437► Subscribe
Turkey9901518► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Dow
Express Scripts
McKinsey
US Army
McKesson
Chinese Patent Office
Harvard Business School
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot